Pilot Study on the Efficacy and Safety of FIBRORESTIL® as an Adjuvant Intralesional Treatment in Patients With Peyronie's Disease Receiving Standard Therapy

NCT07341529 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Peyronie Disease

Interventions

DEVICE: Intralesional hyaluronic acid-based enzymatic medical device
OTHER: Standard conservative treatment for Peyronie's disease

Sponsor

Lyx Institute

Collaborators

[object Object]
[object Object]